253 related articles for article (PubMed ID: 25575139)
1. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
[TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
[TBL] [Abstract][Full Text] [Related]
4. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.
Weingart MF; Roth JJ; Hutt-Cabezas M; Busse TM; Kaur H; Price A; Maynard R; Rubens J; Taylor I; Mao XG; Xu J; Kuwahara Y; Allen SJ; Erdreich-Epstein A; Weissman BE; Orr BA; Eberhart CG; Biegel JA; Raabe EH
Oncotarget; 2015 Feb; 6(5):3165-77. PubMed ID: 25638158
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
[TBL] [Abstract][Full Text] [Related]
7. The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.
Rubens JA; Wang SZ; Price A; Weingart MF; Allen SJ; Orr BA; Eberhart CG; Raabe EH
Neuro Oncol; 2017 Oct; 19(10):1361-1371. PubMed ID: 28582547
[TBL] [Abstract][Full Text] [Related]
8. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
Li Y; Zhang X; Chen D; Ma C
Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
[TBL] [Abstract][Full Text] [Related]
9.
Luan Q; Yang R; Lin L; Li X
Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
[TBL] [Abstract][Full Text] [Related]
10. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
Han S; Han B; Li Z; Sun D
Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
[TBL] [Abstract][Full Text] [Related]
12. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
13. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
[TBL] [Abstract][Full Text] [Related]
14. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
17. High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diffuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2).
Wang Y; Tan J; Wu H; Yi C
Med Sci Monit; 2019 May; 25():3860-3868. PubMed ID: 31124542
[TBL] [Abstract][Full Text] [Related]
18. MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
Shahab S; Rubens J; Kaur H; Sweeney H; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2020 Jul; 79(7):746-753. PubMed ID: 32472116
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
20. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
